<ins id="rtd1r"></ins><ins id="rtd1r"><noframes id="rtd1r"><ins id="rtd1r"></ins>
<cite id="rtd1r"><span id="rtd1r"></span></cite>
<del id="rtd1r"></del>
<menuitem id="rtd1r"><noframes id="rtd1r"><ins id="rtd1r"></ins>
<ins id="rtd1r"><noframes id="rtd1r"><cite id="rtd1r"></cite><ins id="rtd1r"><span id="rtd1r"></span></ins>
<cite id="rtd1r"><noframes id="rtd1r">
Filter By:
  • News
    April 12, 2018

    Doravirine Effective in Treatment-naive Adults With HIV

    A study comparing the efficacy of doravirine and ritonavir-boosted darunavir in adult patients with HIV who were treatment-naive found that doravirine was …

    Read Article
  • News
    April 10, 2018

    Record Number Of Specialty Pharmacies Now Have Accreditation

    The number of accredited specialty pharmacies nearly doubled between 2015 and 2017, according to research by the Drug Channels Institute. The fastest-growi…

    Read Article
  • News
    April 09, 2018

    Pharmacists Can Improve Outcomes

    Pharmacists can improve optimization of medication therapies to improve outcomes and reduce costs. Strategies include allowing pharmacist access to complet…

    Read Article
  • News
    March 22, 2018

    Cimzia Label Update Provides New Information For Women Of Childbearing Age

    The FDA approved a label update of UCB's Cimzia, or certolizumab pegol, to include new data showing a negligible to low risk for drug transfer through plac…

    Read Article
  • News
    March 05, 2018

    Review Finds Switching From Reference Product To Biosimilar ‘Not Inherently Dangerous’

    A review in the journal Drugs found that moving to a biosimilar from a reference drug "is not inherently dangerous, and that patients, healthcare professio…

    Read Article
  • News
    February 13, 2018

    Novartis Gains U.S. Approval For Glatopa For Multiple Sclerosis

    Novartis's Sandoz division has won U.S. approval for a larger dose of its Glatops drug for multiple sclerosis (MS). Click Here to view the original arti…

    Read Article

A smaller focus to make a much larger impact. Our goal is to deliver on every promise we make

Our Mission

Learn More